Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sickle Cell Association of New Jersey is a New Jersey-based nonprofit, community health and advocacy organization focused on supporting individuals and families affected by sickle cell disease. Established in 2009, the organization provides non-medical services including patient and family support, education, transition assistance, resource sharing, advocacy, community outreach, and access-to-research support. SCANJ operates as the New Jersey member chapter of the Sickle Cell Disease Association of America and partners with healthcare professionals, treatment centers, and community organizations across the state. Its activities include support groups, blood drive initiatives, awareness events, newsletters, and public policy advocacy rather than development of proprietary therapeutics. The organization is best characterized as a healthcare nonprofit and patient-services organization rather than a biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sickle Cell Association of New Jersey.